JIANGXI TIANXIN PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 603235 for the last quarter is 489.36 M CNY, and it's 25.44% higher compared to the previous quarter. The net income of Q1 24 is 147.55 M CNY.